Mathur R, Wang Q, Schupp P, Nikolic A, Hilz S, Hong C
Cell. 2024; 187(2):446-463.e16.
PMID: 38242087
PMC: 10832360.
DOI: 10.1016/j.cell.2023.12.013.
Bu W, Li Y
Cold Spring Harb Perspect Med. 2023; 14(3.
PMID: 37217281
PMC: 10810718.
DOI: 10.1101/cshperspect.a041328.
Li T, Forbes M, Fuller G, Li J, Yang X, Zhang W
Oncogene. 2020; 39(11):2243-2257.
PMID: 31925333
PMC: 7347283.
DOI: 10.1038/s41388-020-1154-2.
Bu W, Liu Z, Jiang W, Nagi C, Huang S, Edwards D
Cancer Res. 2018; 79(1):61-71.
PMID: 30401712
PMC: 6318055.
DOI: 10.1158/0008-5472.CAN-18-1087.
Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y
Int J Biol Sci. 2016; 12(4):381-8.
PMID: 27019623
PMC: 4807158.
DOI: 10.7150/ijbs.12947.
Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress.
Hein S, Haricharan S, Johnston A, Toneff M, Reddy J, Dong J
Oncogene. 2015; 35(11):1461-7.
PMID: 26096929
PMC: 4688047.
DOI: 10.1038/onc.2015.206.
Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesis.
Bu W, Zhang X, Dai H, Huang S, Li Y
PLoS One. 2013; 8(11):e78720.
PMID: 24265712
PMC: 3827100.
DOI: 10.1371/journal.pone.0078720.
Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.
Wang J, Bushman J, Wang X, Mayer-Proschel M, Johnson M, Noble M
J Neurosci. 2013; 33(42):16805-17.
PMID: 24133281
PMC: 3797384.
DOI: 10.1523/JNEUROSCI.0546-13.2013.
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.
England B, Huang T, Karsy M
Tumour Biol. 2013; 34(4):2063-74.
PMID: 23737287
DOI: 10.1007/s13277-013-0871-3.
Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model.
Doucette T, Rao G, Yang Y, Gumin J, Shinojima N, Bekele B
Neoplasia. 2011; 13(8):716-25.
PMID: 21847363
PMC: 3156662.
DOI: 10.1593/neo.101680.
Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.
Mimeault M, Batra S
Brain Pathol. 2011; 21(5):479-500.
PMID: 21615592
PMC: 3458583.
DOI: 10.1111/j.1750-3639.2011.00505.x.
Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.
Doucette T, Yang Y, Zhang W, Fuller G, Suki D, Fults D
Int J Cancer. 2010; 129(9):2093-103.
PMID: 21171016
PMC: 3196817.
DOI: 10.1002/ijc.25869.
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis.
Toneff M, Du Z, Dong J, Huang J, Sinai P, Forman J
Neoplasia. 2010; 12(9):718-26.
PMID: 20824048
PMC: 2933692.
DOI: 10.1593/neo.10516.
NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl-N-nitrosourea-induced gliomagenesis.
Briancon-Marjollet A, Balenci L, Fernandez M, Esteve F, Honnorat J, Farion R
Carcinogenesis. 2010; 31(10):1718-25.
PMID: 20651032
PMC: 3308186.
DOI: 10.1093/carcin/bgq154.
The RCAS-TVA system for introduction of oncogenes into selected somatic mammary epithelial cells in vivo.
Reddy J, Li Y
J Mammary Gland Biol Neoplasia. 2009; 14(4):405-9.
PMID: 19936988
DOI: 10.1007/s10911-009-9157-1.
Design and application of oncolytic HSV vectors for glioblastoma therapy.
Grandi P, Peruzzi P, Reinhart B, Cohen J, Chiocca E, Glorioso J
Expert Rev Neurother. 2009; 9(4):505-17.
PMID: 19344302
PMC: 3219506.
DOI: 10.1586/ern.09.9.
Glioma formation, cancer stem cells, and akt signaling.
Hambardzumyan D, Squatrito M, Carbajal E, Holland E
Stem Cell Rev. 2008; 4(3):203-10.
PMID: 18595010
DOI: 10.1007/s12015-008-9021-5.
Trp53 deletion stimulates the formation of metastatic pancreatic tumors.
Morton J, Klimstra D, Mongeau M, Lewis B
Am J Pathol. 2008; 172(4):1081-7.
PMID: 18310506
PMC: 2276406.
DOI: 10.2353/ajpath.2008.070778.
Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities.
Fraser M, Bayazitov I, Zakharenko S, Baker S
Neuroscience. 2007; 151(2):476-88.
PMID: 18082964
PMC: 2278004.
DOI: 10.1016/j.neuroscience.2007.10.048.
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
Mimeault M, Hauke R, Mehta P, Batra S
J Cell Mol Med. 2007; 11(5):981-1011.
PMID: 17979879
PMC: 4401269.
DOI: 10.1111/j.1582-4934.2007.00088.x.